Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 20 family member A18, pseudogene (ANKRD20A18P)
- Target
- ANKRD20A18P
- Molecular classification
- Pseudogene, Long non-coding RNA (lncRNA) (potential if transcribed), Other
01
Overview
Ankyrin repeat domain 20 family member A18, pseudogene (ANKRD20A18P), also known as C21orf126, is an annotated human pseudogene located on chromosome 21 (21:15,436,646-15,441,408, GRCh37)[3][5][6][8]. It does not appear to encode a functional protein, as it is categorized as an "unprocessed pseudogene" and has no protein-coding transcript[1][3][8]. Although typically regarded as non-functional genomic elements, some pseudogenes have been shown to act as regulatory RNAs (such as miRNA sponges or sources of siRNAs) that influence the expression of protein-coding genes[2][4]. However, there is no evidence that ANKRD20A18P is directly involved in such regulatory pathways or in disease processes. It is not considered a therapeutic target, and there are no approved drugs or investigational compounds that interact with this pseudogene.
- Other names
- C21orf126Ankyrin repeat domain 20 family, member A3 pseudogeneANKRD20A18P
02
Mechanism of action
Not applicable (no direct pharmacological targeting known)
03
Biological functions
May participate in post-transcriptional gene regulation (by acting as a miRNA decoy or via siRNA pathways, inferred based on pseudogene biology)Other
04
Disease associations
Other (no direct evidence for involvement in specific diseases)
05
Safety considerations
Not applicable (not a therapeutic target, no evidence of direct biological risk or druggability)
06
Interacting drugs
None known
07
Biomarkers
None known
Beyond the preview
Go deeper on Ankyrin repeat domain 20 family member A18, pseudogene (ANKRD20A18P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A18, pseudogene (ANKRD20A18P).